
Donald E Cutlip MD
Interventional Cardiology
Professor of Medicine, Beth Israel Deaconess Medical Center
Join to view full profile
Beth Israel Deaconess Med Ctr330 Brookline Ave Es217Boston, MA 02215
Phone+1 617-667-7455
Fax+1 617-632-7460
Dr. Cutlip is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Cardiovascular Disease, 1992 - 1996
University of ConnecticutResidency, Internal Medicine, 1979 - 1983
University of South Florida College of MedicineClass of 1979
Certifications & Licensure
MA State Medical License 1993 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification Quality Data Center, Massachusetts eHealth Collaborative (MAeHC), 2012-2017
- CMS Meaningful Use Stage 2 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2017
- CMS Meaningful Use Stage 1 Certification Online Medical Record, Beth Israel Deaconess Medical Center, 2012-2017
Clinical Trials
Publications & Presentations
PubMed
- 2 citationsSirolimus-Eluting Balloon vs Repeat Drug-Eluting Stent or Balloon Angioplasty for Coronary In-Stent Restenosis.Donald E Cutlip, Roxana Mehran, Samin Sharma, Gheorghe Doros, Brian Jefferson
Journal of the American College of Cardiology. 2026-07-07 - Type 2 diabetes in heart failure with preserved and mildly reduced ejection fraction: insights from the REDUCE-LAP-HF II trial.Misha Dagan, Shane Nanayakkara, Anna L Beale, Jan Komtebedde, Uma Mylavarapu
ESC Heart Failure. 2026-07-04 - Standardized End Point Definitions for Clinical Trials in Thoracic Aortic Repair: A Consensus Report From the ARCH-Academic Research Consortium.Adam W Beck, Nimesh D Desai, Dorothy Abel, Cherrie Z Abraham, Joseph E Bavaria
Circulation. 2026-06-02
Journal Articles
- Original Investigations Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents: BIOFLOW V 2-Year ResultsDavid E Kandzari, Ron Waksman, Donald E Cutlip, Elie G Gharib, ScienceDirect
- Standardized End Point Definitions for Coronary Intervention Trials: The Academic Research Consortium-2 Consensus DocumentWilliam F Fearon, John Spertus, Roxana Mehran, Donald Cutlip, Gregg W Stone, Mitchell W Krucoff, European Heart Journal
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
Meta-Analysis: Prasugrel the Best P2Y12 Inhibitor After PCI?June 5th, 2026
INFINITY-SWEDEHEART: ‘Unlocking’ Stent’s Benefits Seen over TimeOctober 29th, 2025
INFINITY-SWEDEHEART: ‘Unlocking’ Device Bests DES over TimeOctober 29th, 2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









